NDC 30237-8900-5 - PROVENGE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 30237-8900
- Requested NDC
- 30237-8900-5
- Package NDCs from labels
- 30237-8900-5, 30237-8900-6
- Manufacturer
- Dendreon Pharmaceuticals LLC | Ann Davis
- Effective date
- 2025-10-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PROVENGE - Dendreon Pharmaceuticals LLC | Ann Davis | Dendreon Pharmaceuticals LLC | Ann Davis | 2025-10-03 | CELLULAR THERAPY |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 30237-8900-5 | PROVENGE | 1 in 1 BAG | INJECTION | 1 | 19 | |
| 30237-8900-6 | PROVENGE | 1 in 1 CARTON | INJECTION | 1 | 19 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 30237-8900 | PROVENGE (SIPULEUCEL-T) INJECTION [DENDREON PHARMACEUTICALS LLC] | 18 | Current NDC, Legacy NDC, 2 package rows | 20241012_8309b497-5d4e-4408-ac0c-2452c11c8a35.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 30237-8900-6 | ML - Milliliter | 30237-8900 | dcc0a576-1c5a-4f3c-a7d1-792d34098abf | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Sipuleucel-T | ACTIVE INGREDIENT | 8Q622VDR18 | PROVENGE (SIPULEUCEL-T) INJECTION [DENDREON CORPORATION] | 9 | |
| Sipuleucel-T | ACTIVE MOIETY | 8Q622VDR18 | PROVENGE (SIPULEUCEL-T) INJECTION [DENDREON CORPORATION] | 9 | |
| Calcium Chloride | INACTIVE INGREDIENT | M4I0D6VV5M | PROVENGE (SIPULEUCEL-T) INJECTION [DENDREON CORPORATION] | 9 | |
| Potassium Chloride | INACTIVE INGREDIENT | 660YQ98I10 | PROVENGE (SIPULEUCEL-T) INJECTION [DENDREON CORPORATION] | 9 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | PROVENGE (SIPULEUCEL-T) INJECTION [DENDREON CORPORATION] | 9 | |
| Sodium Lactate | INACTIVE INGREDIENT | TU7HW0W0QT | PROVENGE (SIPULEUCEL-T) INJECTION [DENDREON CORPORATION] | 9 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | PROVENGE (SIPULEUCEL-T) INJECTION [DENDREON CORPORATION] | 9 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | cc15ef60-6956-4d34-b86d-72cdd0c0c0bb | 2025-10-02 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | Granules Pharmaceuticals Inc. | b3d4d5b5-2898-ae3d-e053-2a95a90a6d04 | 2025-09-30 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Granules Pharmaceuticals Inc | c1f4832d-4d5c-8c49-e053-2a95a90ac9fe | 2025-09-30 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Bryant Ranch Prepack | 0e875691-7372-46ac-80a1-946e08b40061 | 2025-09-30 | Warnings, Adverse reactions | 660YQ98I10 |
| Xpect Eyewash | EYEWASH | Cintas Corporation | 1d69365d-662b-4248-8fa9-1629451b549a | 2025-09-30 | Warnings | 059QF0KO0R |
| CheBoho TEA TREE ACNE | CHEBOHO TEA TREE ACNE | Opalshi(Guangzhou)E-commerce Co. Ltd. | 3fc4cf84-b2da-c593-e063-6394a90abc5c | 2025-09-27 | Warnings | 059QF0KO0R |
| Potassium Chloride | POTASSIUM CHLORIDE | Epic Pharma, LLC | 00615fad-ad3b-46e8-a89d-48290d937ae2 | 2025-09-23 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Macleods Pharmaceuticals Limited | 89d827c8-91af-4bfd-a846-62e55824e983 | 2025-09-22 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Major Pharmaceuticals | a9d68a40-75e3-4c5c-b5d7-1d6160527fa7 | 2025-09-22 | Warnings, Adverse reactions | 660YQ98I10 |
| Sterile Water | WATER | ProPharma Distribution | 3f2ae880-852f-b45d-e063-6394a90aa1cc | 2025-09-19 | Warnings, Adverse reactions | 059QF0KO0R |
| Jet Lag | ECHINACEA, ALUMINA, ARALIA QUINQUEFOLIA, ARGENTUM, ARNICA MONTANA, ARSENICUM ALBUM, BAPTISIA TINCTORIA, BRYONIA, CANTHARIS, CHELIDONIUM MAJUS, CONIUM MACULATUM, GELSEMIUM SEMPERVIRENS, IODIUM, KALI CARBONICUM, KALI IODATUM, LYCOPODIUM CLAVATUM, LYCOPUS VIRGINICUS, NATRUM MURIATICUM, NUX VOMICA, PHOSPHORUS, PHYTOLACCA DECANDRA, PULSATILLA, RHUS TOXICODENDRON, SABAL SERRULATA, THYROIDINUM. | Newton Laboratories, Inc. | 9c21c935-4ebc-1efd-e053-2995a90aa156 | 2025-09-18 | Warnings | 451W47IQ8X |
| Potassium Chloride | POTASSIUM CHLORIDE | NCS HealthCare of KY, LLC dba Vangard Labs | 542e16b0-44db-490f-b44e-4c88a6e3d8b8 | 2025-09-17 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Strides Pharma Science Limited | 0224e5b3-3c49-4e6e-aa78-1abcc6969246 | 2025-09-17 | Warnings, Adverse reactions | 660YQ98I10 |
| Calcium Chloride | CALCIUM CHLORIDE | ProPharma Distribution | 3eef0115-26f6-2abe-e063-6294a90aa289 | 2025-09-16 | Adverse reactions | M4I0D6VV5M |
| Perikabiven | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | Fresenius Kabi USA, LLC | c2eb5522-8572-45f4-869d-42f9fd251bb6 | 2025-09-15 | Warnings, Adverse reactions | 660YQ98I10 M4I0D6VV5M |
| Kabiven | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | Fresenius Kabi USA, LLC | afeb4837-a759-4484-a76e-e04611c459e7 | 2025-09-11 | Warnings, Adverse reactions | 660YQ98I10 M4I0D6VV5M |
| GAVILYTE-N | POLYETHYLENE GLYCOL-3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE AND SODIUM BICARBONATE | Lupin Pharmaceuticals,Inc. | 27195187-75a3-431f-90d9-84da1b94e849 | 2025-09-10 | Warnings, Adverse reactions | 451W47IQ8X 660YQ98I10 |
| GaviLyte - C TM | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES WITH FLAVOR PACK | Lupin Pharmaceuticals,Inc. | a8b15625-ca7c-4d57-9f36-3ac2a6d13665 | 2025-09-10 | Warnings, Adverse reactions | 451W47IQ8X 660YQ98I10 |
| GAVILYTE G TM | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | Lupin Pharmaceuticals,Inc. | 3978822b-6473-4072-9f80-20ceb9bea355 | 2025-09-10 | Warnings, Adverse reactions | 451W47IQ8X 660YQ98I10 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | Preferred Pharmaceuticals Inc. | 87f369cf-40e5-4f91-aa42-ae986fce6544 | 2025-09-10 | Warnings, Adverse reactions | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.